These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 13881995

  • 1. Studies on the biochemical pharmacology of 5-iodo-2'-deoxycytidine in vitro and in vivo.
    CRAMER JW, PRUSOFF WH, WELCH AD, SARTORELLIAC, DELAMORE IW, VON ESSEN CF, CHANG PK.
    Biochem Pharmacol; 1962 Aug; 11():761-8. PubMed ID: 13881995
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The potentiation by 5-iodo-2'-deoxyuridine (IUDR) of the tumor-inhibitory activity of 5-fluoro-2'-deoxyuridine (FUDR).
    HEIDELBERGER C, GRIESBACH L, GHOBAR A.
    Cancer Chemother Rep; 1960 Feb; 6():37-8. PubMed ID: 14400595
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Studies in the mouse of the pharmacology of 5-iododeoxyuridine, an analogue of thymidine.
    PRUSOFF WH, JAFFE JJ, GUNTHER H.
    Biochem Pharmacol; 1960 May; 3():110-21. PubMed ID: 14435159
    [No Abstract] [Full Text] [Related]

  • 6. Summary of current information on 6-azauridine.
    HANDSCHUMACHER RE, CALABRESI P, WELCH AD, BONO V, FALLON H, FREI E.
    Cancer Chemother Rep; 1962 Aug; 21():1-18. PubMed ID: 13904321
    [No Abstract] [Full Text] [Related]

  • 7. Pharmacological and clinical studies with triacetyl 6-azauridine.
    HANDSCHUMACHER RE, CREASEY WA, FINK ME, CALABRESI P, WELCH AD.
    Cancer Chemother Rep; 1962 Feb; 16():267-9. PubMed ID: 13904322
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Experimental evaluation of potential anticancer agents. IX. The ribonucleosides and ribonucleotides of two purine antagonists.
    MONTGOMERY JA, SCHABEL FM, SKIPPER HE.
    Cancer Res; 1962 May; 22():504-9. PubMed ID: 14475543
    [No Abstract] [Full Text] [Related]

  • 12. A comparative study of the anticancer activity of some S-substituted derivatives of 6-mercaptopurine and their ribonucleosides.
    MONTGOMERY JA, JOHNSTON TP, GALLAGHER A, STRINGFELLOW CR, SCHABEL FM.
    J Med Pharm Chem; 1961 Mar 01; 3():265-88. PubMed ID: 14475542
    [No Abstract] [Full Text] [Related]

  • 13. A proposed mechanism of action of 1-beta-D-arabinofuranosyl-cytosine as an inhibitor of the growth of leukemic cells.
    CHU MY, FISCHER GA.
    Biochem Pharmacol; 1962 Jun 01; 11():423-30. PubMed ID: 13879359
    [No Abstract] [Full Text] [Related]

  • 14. OETTGEN HF, REPPERT JA, COLEY V: Studies on the synergism of fluorinated pyrimidines and certain pyrimidine and purine derivatives against transplanted mouse leukemia.
    BURCHENAL JH.
    Cancer Chemother Rep; 1960 Feb 01; 6():1-5. PubMed ID: 13806003
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Effect of 6-azauracil riboside on spermogenesis in rats].
    KAPELLER K, SANDOR L, WINKLER A, KRATOCHVIL M.
    Neoplasma; 1960 Feb 01; 7(Suppl 1)():141-3. PubMed ID: 13751250
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.